Table 3.
Summary of case reports found in the literature with transitional cell carcinoma recurrence within an intestinal urinary diversion (TCCUD) after radical cystectomy
Author | Journal | Age/sex | Histology at cystectomy | Urinary diversion | Recurrence site | Symptoms at presentation | Months after cystectomy | Upper Tract TCC | Treatment of the recurrence | Additional therapy | Final pathology of TCCUD | Death | Follow-up (months) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Soloway et al. [7] | J Urol. 1972 | 71/F | N/A | IC | UIA | GE and PC | 19 | Yes | RT | N/A | TCC | Yes | 24 |
Soloway et al. [7] | J Urol. 1972 | 57/M | N/A | IC | UIA | PC | 13 | Yes | PR and formation of a new conduit + NUT | N/A | TCC | Yes | 15 |
Grabstald [8] | J Urol. 1974 | 58/M | pT3N0 | IC | Around the ileal stoma | Tumor formation around the ilea! stoma | 48 | No | PR | No | TCC infiltrating grade 2 carcinoma with deep invasion into the muscularis of the ileal conduit. | No | 18 |
Wajsman et al. [9] | Urology. 1975 | 57/M | N/A | IC | UD | GE | 108 | Yes | PR | CHT | TCC grade II | No | 12 |
Banigo et al. [10] | J Urol. 1975 | 69/M | N/A | IC | UIA | N/A | 36 | Yes | PR + Resection of distal left ureter | N/A | TCC | No | 9 |
Allan DM et al. [11] | Br J Urol. 1976 | 56/M | N/A | IC | UIA | abscess | 15 | Yes | TR + NUT | None performed | TCC | N/A | N/A |
Rubin et al. [12] | Urol Radiol. 1979 | 68/F | N/A | IC | UD | GE and PC | 78 | No | PR and reanastomosis of ileal conduit | None performed | TCC | Yes | 1 day post surgery |
Curran et al. [13] | Postgrad Med J. 1986 | 66/F | T1G2 | IC | UD | GE | 48 | Yes | PR + NUT | None performed | TCC noninvasive grade I and II | N/A | N/A |
Moskovitz et al. [14] | Urol Int. 1986 | 52/M | N/A | IC | UIA | N/A | 15 | Yes | NUT+ resection of the ureter with the cuff of ileum. Reanastomosis of the loop. | None performed | TCC | N/A | N/A |
Roberts et al. [15] | J Urol. 1987 | 69/F | T3bNoMx | IC | UD | UTI and upper tract obstruction | 4 | No | PR + distal portion of the conduit was fashioned into a new stoma | CHT | TCC poorly differentiated transitional | Yes | 4 |
Rosvanis et al. [16] | Cancer. 1989 | 73/M | CIS | IC | UD | GE | 60 | Yes | NUT + PR | None performed | TCC noninvasive grade 2 | Yes | 12 |
Mulholland et al. [17] | BrJ Urol. 1993 | 54/M | N/A | IC | UD | GE | N/A | Yes | PR + Resection of 3 cm of ureter | None performed | Grade II TCC without a direct invasion of the submucosa N0M0 | N/A | N/A |
Garcia et al. [18] | Br J Urol 1993 | 77/M | pT2G3L1 | IC | UD | GE | 36 | No | Not performed | CHT | TCC | N/A | N/A |
Corral et al. [19] | J Urol. 1993 | 54/M | pT3aNo | IC | UD | GE | 12 | No | PR | Preoperative and postoperative CHT | Poorly differentiated TCC with transmural extension into serosal adipose tissue with marked angiolymphatic invasion. | No | 54 |
Carter et al. [20] | Eur Urol. 1996 | 67/M | PT3. No Mo G2 | IC | UD | GE, UTI, PC | 24 | No | TR + new conduit fashioned away from the original stoma | CHT | TCC invading the full thickness of the bowel wall to the surrounding retroperitoneal | Yes | N/A |
Inobe T et al. [21] | Int J Urol. 1999 | 66/M | pT3bG3pN0 | IC | UD | No symptoms | 4 | No | Not performed | Palliative RT | TCC | Yes | 7 |
Sanchez Zalabardo et al. [22] | Actas Urol Esp. 2001 | 57/M | pT3aN0M0G3 | OIN | UD | N/A | 108 | Yes | PR | CHT and RT | TCC | No | 3 |
Shioji et al. [23] | Urol Nephrol. 2001 | 67/M | pT3bN2M0 | IC | UIA + UD | GE | 11 | Yes | PR + resection of the ureteroileal junction | None performed | TCCG2 | Yes | 19 |
Hara et al.[24] | Urology. 2003 | 67/M | Invasive bladder cancer | SCN | UIA + UD | N/A | 96 | Yes | TR +NUT | None performed | TCC, grade 3 + CIS | N/A | N/A |
Herawi et al. [25] | Urology. 2006 | 60/M | N/A | OIN | UD | PC | 3 | Yes | Biopsies of the ileocolonic neobladder | None performed | TCC noninvasive low- grade | N/A | N/A |
Ide et al. [26] | Urology. 2007 | 73/M | Grade 3, Stage pT1 | OIN | UIA | PC | 144 | Yes | TR+ NUT+ conversion to ileal conduit + urethrectomy | None performed | TCC pT2, grade 3. CIS, | No | 6 |
Moore et al. [27] | Urology. 2007 | 62/M | pT3N0M0 | OIN | UD | GE | 12 | No | TR+ conversion to ileal conduit + urethrectomy + mesenteric lymphadenectomy. | CHT | TCC high-grade. Positive metastatic lymph nodes | Yes (multiple metastasis liver, lung, and adrenal gland) | 15 |
Kotb et al.[28] | Ecancermedicalscience. 2012 | 59/F | pT2N0, with squamoid differentation | OIN | UD | GE | 156 | No | TR+ continent reservoir Urethrectomy | None performed | TCC pT3 | No | 3 |
Hadzi-Djokic et al. [29] | Vojnosanit Pregl. 2013 | 65/M | pT2G2N0M0 | OIN | UIA | GE | 144 | Yes | PR + NUT | None performed | TCC pT2bG2 | Yes, for laryngeal carcinoma | 12 |
Yamashita et al. [30] | Int J Urol. 2014 | 74 /M | pT3aN0M0 + CIS | OIN | UD | GE and PC | 72 | Yes | Endoscopic resection | BCG instillation for 8 months | TCC pTa + CIS | N/A | N/A |
Cakmak et al. [31] | Case Rep Urol. 2014 | 51/M | grade 3, stage pT1N0M0 | OIN | UD | GE | 132 | No | Endoscopic resection | None performed | TCC low-grade | Yes | 18 |
Kawamoto et al. [32] | Urology Case Reports. 2016 | 61/M | cT2 pTIS,G3N0 | OIN | UIA | PC | 108 | Yes | TR+ conversion to ileal conduit + NUT | CHT | TCC pT2b, grade 3 | No | 20 |
Cherbanyk et al. [33] | Case Rep Urol. 2016 | 66/M | pT3a pN1 (1/13) cM0, G3, L1 | OIN | UD | GE | 108 | No | Endoscopic resection | CHT | TCC tumor invaded the muscularis propria of the ileal neobladder | N/A | Recurrence in few months in right frontal cerebral mass |
Groen, et al. [34] | BMJ Case Rep, 2017 | 65/M | cT4aN2M1 (pT0N0Mx after neoadjuvant chemotherapy) | OIN | UIA | N/A | 108 | No | TR+ conversion to ileal conduit | CHT and retroperitoneal lymph one year after urinary diversion | TCC pT2b, N1, grade 3 | No | 24 |
Doshi et al. [35] | Case Rep Urol. 2019 | 71/M | pT3aN0 + CIS | OIN | UD | PC | 132 | No | TR+ conversion to ileal conduit | CHT (after cystectomy) | TCC HG extending into the surrounding fat | N/A | N/A |
OIN – orthotopic ileal neobladder; SCN – sigmoid colon neobladder; IC – Ileal Conduit; GE – gross hematuria; PC – positive urine cytology; UTI – urinary tract infection; N/A – not available; UIA – ureteroileal anastomosis; UD – recurrence with the urinary diversion, away from both ureteroileal anastomoses; CHT – chemotherapy, RT – radiation therapy; NUT– nephroureterectomy; TR – total resection of the neobladder (with the mesentery); PR – partial resection; HG – high-grade; TCC – transitional cell carcinoma